Patents by Inventor Stirling John Edwards

Stirling John Edwards has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of elicting or inducing an immune response
    Patent number: 9150619
    Abstract: A method for eliciting or inducing an immune response in a human or animal subject, comprises administering to said subject a composition comprising an antigen and an adjuvant, wherein the composition is administered to the subject by the intra-lung route.
    Type: Grant
    Filed: August 31, 2007
    Date of Patent: October 6, 2015
    Assignees: CSL Limited, The University of Melbourne
    Inventors: Stirling John Edwards, Martin John Pearse, Jean-Pierre Yves Scheerlinck, Philip Sutton
  • METHOD OF ELICTING OR INDUCING AN IMMUNE RESPONSE
    Publication number: 20090324642
    Abstract: A method for eliciting or inducing an immune response in a human or animal subject, comprises administering to said subject a composition comprising an antigen and an adjuvant, wherein the composition is administered to the subject by the intra-lung route.
    Type: Application
    Filed: August 31, 2007
    Publication date: December 31, 2009
    Inventors: Stirling John Edwards, Martin John Pearse, Jean-Pierre Yves Scheerlinck, Philip Sutton
  • Papillomavirus polyprotein constructs
    Patent number: 6726912
    Abstract: A papillomavirus polyprotein construct comprises at least two amino acid sequences fused directly or indirectly together, each of the sequences being the sequence of an early ORF protein of papillomavirus or an immunogenic variant or fragment thereof, and at least one of said sequences being other than the E6 or E7 protein sequence or an immunogenic variant or fragment thereof. Nucleic acid molecules encoding the polyprotein construct, prophylactic or therapeutic compositions comprising the polyprotein construct or the nucleic acid molecule, and methods for eliciting an immune response against papillomavirus in a host animal are also provided.
    Type: Grant
    Filed: December 11, 2001
    Date of Patent: April 27, 2004
    Assignees: CSL Limited, University of Queensland of St. Lucia
    Inventors: Elizabeth Ann Webb, Mary Brigid Margetts, John Cooper Cox, Ian Frazer, Nigel Alan John McMillan, Mark Philip Williams, Margaret Bridget Holland Moloney, Stirling John Edwards
  • Papillomavirus polyprotein constructs
    Patent number: 6365160
    Abstract: Peptides, antibodies and recombinant expression systems or cells that contain and express a DNA insert of HPV encoding a region of a papilloma induced or a papilloma protein, such as E6 or E7, are produced. Compositions containing these peptides, antibodies and/or recombinant cells are utilized as immunogenic compositions and in methods for inhibiting and treating HPV infection and tumor initiation and progression. Specific peptides and recombinant cells, such as vaccinia virus and tumor cells, that express epitopic regions of the HPV16 E6 or E7 nucleoprotein are particularly described.
    Type: Grant
    Filed: April 21, 1998
    Date of Patent: April 2, 2002
    Assignees: CSL Limited, The University of Queensland
    Inventors: Elizabeth Ann Webb, Mary Brigid Margetts, John Cooper Cox, Ian Frazer, Nigel Alan John McMillan, Mark Philip Williams, Margaret Bridget Holland Moloney, Stirling John Edwards
  • Variants of human papilloma virus antigens
    Patent number: 6306397
    Abstract: Variants of human papilloma virus (HPV) E6 and E7 proteins able to elicit a humoral and/or cellular immune response against HPV in a host animal but not being cell-transforming in the host animal are disclosed, and are useful in treatment or prevention of diseases or conditions involving HPV.
    Type: Grant
    Filed: July 23, 1999
    Date of Patent: October 23, 2001
    Assignees: CSL Limited, The University of Queensland
    Inventors: Stirling John Edwards, John Cooper Cox, Elizabeth Ann Webb, Ian Frazer
  • Method for protein expression
    Patent number: 6303128
    Abstract: A vector system for expressing foreign proteins or polypeptides in bacteria such as E. coli is disclosed. The vector system is especially useful in obtaining expression of non-transforming variants of human papilloma virus antigens.
    Type: Grant
    Filed: July 23, 1999
    Date of Patent: October 16, 2001
    Assignee: CSL Limited
    Inventors: Elizabeth Ann Webb, Stirling John Edwards
  • Variants of human papillomavirus antigens
    Patent number: 6004557
    Abstract: Variants of human papilloma virus (HPV) E6 and E7 able to elicit a humoral or cellular immune response against HPV in a host animal but not being cell-transforming in the host animal are disclosed, and are useful in treatment or prevention of diseases or conditions involving HPV.
    Type: Grant
    Filed: September 22, 1997
    Date of Patent: December 21, 1999
    Assignees: CSL Limited, The University of Queensland
    Inventors: Stirling John Edwards, John Cooper Cox, Elizabeth Ann Webb, Ian Frazer